FDA Investigator Nikki S Ramirez
Nikki S Ramirez has conducted inspections on 14 sites in 2 countries as of 08 Jan 2014. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
08 Jan 2014
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
India,
United States of America
FDA Investigators that have inspected at least one site in common with Nikki S Ramirez:
Addam S Reynolds,
Alberto A Viciedo,
Amy Chen,
Amy L Singer,
Amy M Cramer,
Amy N Chen,
Andrew J Molesky,
Annemarie Bodnar,
Annet R Rajan,
Barbara J Maulfair,
Brandon C Heitmeier,
Carl A Perez,
Charles R Cote, RIC,
Craig W Swanson,
Cynthia M Goudeau,
Daniel J Grabicki,
Deborah B Nixon,
Devon Jenkins,
Dhaval H Patel,
Dipesh K Shah,
Donald L Lech,
Douglas C Kovacs,
Dr. Gopa Biswas, PhD,
Eileen A Liu,
Emest F Bizjak,
Emmanuel Jramos Maldonado,
Eric J Cunningham,
Eric M Mueller, PharmD,
Eric Rothschild,
Erin D Mccaffery,
Farhana Khan,
Frank J Marciniak,
Frederick F Razzaghi,
Gianine E Tompkins,
Guerlain Ulysse,
Hasan A Irier, PhD,
Helen B Ricalde,
Helen Verdel,
Ivis L Negron,
James C Maclaughlin,
James S Cartwright,
Jared P Stevens,
Jay B Shah,
Jay T Wong,
Jessica M Monteiro,
Jessica S Estriplet,
Jogy George,
Jose A Lopez,
Jose Acruz Gonzalez,
Jose M Cayuela,
Joseph F Mcginnis, RPh,
Joy Rkozlowski Klena,
Justin A Boyd,
Karen A Briggs,
Karen E D'orazio,
Kari M Johansen,
Katherine Szestypalow,
Kelli F Dobilas,
Kellia N Hicks,
Kelly Doremus,
Kenneth H Williams,
Kevin Obrien,
Kinh Q Mac,
Kristina L Conroy,
Kristy A Zielny,
Li Li,
Liatte Kreuger, PharmD,
Luella J Rossi,
Makini Cobourne Duval, PhD,
Marea K Harmon,
Margaret M Sands,
Maria Estrella,
Maria V Price,
Melba Trivera Clavell,
Melissa A Zuppe,
Melissa B Libby,
Melissa T Roy,
Merril E Racke,
Michael R Klapal,
Michael Serrano,
Monika Borkowska,
Muralidhara B Gavini, PhD,
Nancy F Scheraga,
Nancy M Espinal,
Nicholas A Violand,
Niketa Patel,
Paige R Mccoy,
Paul L Bellamy,
Rachael O Oyewole,
Regina T Brown,
Rita K Kabaso,
Robert G Ruff,
Robert M Barbosa,
Robert Sharpnack,
Rose Ljean Mary,
Russell J Glapion,
Schultz,
Scott B Laufenberg,
Scott T Ballard,
Seneca D Toms,
Sherry G Bous,
Sinai I Davis,
Stephen J Mottola,
Stephenie M Ortiz,
Steven A Gonzales,
Susan M Jackson,
Susanna E Ford,
Tara G Bizjak,
Tara R Gooen,
Thomas J Arista,
Tonia F Bernard,
Tressa T Lewis,
Valerie C Reed,
Wei Wang, PhD,
Xiaokuang Lai, PhD,
Xiuju Lu,
Yvesna C Blaise,
Zakaria I Ganiyu,
Zhaoyang Meng
Nikki S Ramirez's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2013 | FDA 483 | Zydus Lifesciences Limited - Form 483, 2013-08-19 |
June, 2013 | EIR | LEADING PHARMA, LLC - EIR, 2013-06-12 |
November, 2013 | EIR | Avantor Performance Materials, LLC - EIR, 2013-11-15 |
July, 2013 | FDA 483 | ISP Sutton Laboratories - Form 483, 2013-07-11 |
January, 2014 | FDA 483 | Genzyme Corporation - Form 483, 2014-01-21 |
June, 2013 | FDA 483 | LEADING PHARMA, LLC - Form 483, 2013-06-12 |
December, 2013 | EIR | Givaudan Flavors Corporation - EIR, 2013-12-12 |
July, 2013 | EIR | ISP Sutton Laboratories - EIR, 2013-07-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more